[Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma
Peijie Chen, Jing Quan, Lu Jin, Canbin Lin, Weijie Xu, Jinling Xu, Xin Guan, Zebo Chen, Liangchao Ni, Shangqi Yang, Yun Chen, Yongqing Lai
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRenal cell carcinoma treatment · Ferroptosis and cancer prognosis · Renal and related cancers
Exp Ther Med 15:4039–4046, 2018; DOI: 10.3892/etm.2018.5881
Subsequently to the publication of the above article, the authors drew to the attention of the Editor that Figs. 5 and 6 both contained errors that arose inadvertently during the assembly of these figures. With the scratch wound assay data shown in Fig. 5A on p. 4043, the data panels showing the results from the ‘786-O/NC’ and ‘786-O/miR-216a inhibitor’ experiments at t=0 h were overlapping, and similarly, the’786-O/Migration, miR-216a mimic’ and ‘786-O/Migration, NC’ panels in Fig. 6A on p. 4044, showing the results of Transwell migration assay experiments, were overlapping, suggesting that these data were derived from the same original sources. After having consulted their original data, the authors realized where the errors occurred in assembling these figures, and were able to present the correct data for these figures to the Editorial Office.
New versions of Figs. 5 and 6, showing the correct data for the ‘786-O/miR-216a inhibitor’ experiment at t=0 h and the ‘786-O/NC’ experiment in Figs. 5A and 6A respectively) are shown on the next page. Note that the revised data shown for these figures do not affect the overall conclusions reported in the paper. All the authors agree with the publication of this corrigendum; furthermore, they apologize to the Editor of Experimental and Therapeutic Medicine and to the readership for any inconvenience caused.